https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis
HIV Prevention Methods

PrEP (HIV Pre-Exposure Prophylaxis)

The Latest

lab testing
News

This Week in HIV Research: The Frustrating Relativity of Efficacy

March 26, 2020: Lopinavir/ritonavir falls short against COVID-19; impact of PrEP scale-up on HIV diagnoses; long-term cost-effectiveness of various HIV interventions; disparities in virologic suppression among young people.

pill bottles and cash
Conference Coverage

A PrEP Pricing Pickle: Descovy Will Need a Drastic Discount to Be Worthwhile, Study Finds

With Truvada going generic soon in the U.S., public health officials will need to make some decisions to make access to both drugs sustainable.

blue pills on blue background
News

This Week in HIV Research: PrEP Relief

Feb. 13, 2020: PrEP's psychosocial benefits; supplementing ADAP with Obamacare plans; lack of HIV and HCV testing for people who inject drugs; frailty is more common, but not more deadly, in HIV settings.

Ricky Varghese
Interviews

‘Raw’ Is the Book That Contemplates What It Means to Bareback

Barebacking is not just an act. It’s a stand-in for so many of our feelings about queer sexuality.

HIV Transmission illustration
Reference

No-BS Basics on HIV Prevention

Thanks to decades of extensive scientific research, we now have extremely reliable ways to prevent HIV transmission. Here’s a breakdown of the tools you can use to prevent HIV.

large classroom from back of room
Features

How to Develop a Curriculum Around HIV

Teaching young people of all ages about HIV is essential. But how do you start to outline a class?

couple holding hands
Personal Stories

So You've Disclosed Your HIV Status to a Love Interest. Now What?

Sex and intimacy can be a challenge if your HIV-negative partner is still afraid of you.

Undetectable = Untransmittable -- CATIE Signs On Img
News Analysis

Factors Associated With Hepatitis C Infection Among Men Who Take PrEP

IPERGAY scientists recommended that clinicians screen patients who request PrEP, as well as patients who are already using it, for a number of key HCV risk factors.

Peter Staley Brenda Emily Goodrow and Mark Lemley credit Ivy Arce
Interviews

Oral Arguments in Antitrust Case Against HIV Drug Companies Began Last Week. Plaintiff Peter Staley Explains the Case

The case could change the way pharma companies make agreements to keep generic versions of single-tablet pills at bay.

Senior woman receives prescription medication from doctor
News Analysis

Should All PrEP Users on Truvada Switch to Descovy? These Leading Docs Say, ‘Not So Fast.’

Many fear the push to put more people on the new brand-name drug before Truvada goes generic this year.